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Abstract
Human lung squamous cell carcinoma (SCC) is highly associated with increased pulmonary macrophage inﬁltration.
Previously, we showed that marked pulmonary inﬁltrating macrophages were required for spontaneous lung SCC
development in a mouse model (L-IkkαKA/KA, KA/KA) that resembles human lung SCC. Interestingly the lung SCC-
associated macrophages speciﬁcally express elevated inducible nitric oxide synthase (NOS2). However, the role of
macrophage NOS2 in lung carcinogenesis has not been explored. Here, we show that NOS2 ablation inhibits
macrophage inﬁltration, ﬁbrosis, and SCC development in the lungs of KA/KA mice. Macrophage NOS2 was found to
circulate inﬂammation and enhance macrophage migration and survival. NOS2 promotes foamy macrophage
formation characterized with impaired lipid metabolism. NOS2 null bone marrow transplantation reduces foamy
macrophage numbers and carcinogenesis in KA/KA chimaeras. This ﬁnding sheds light on a new mechanism by which
macrophage NOS2 increases pulmonary inﬂammatory responses and macrophage survival and impairs macrophage
lipid metabolism, thereby promoting lung SCC formation.
Introduction
Lung cancer is a leading cause of all cancer-related
deaths worldwide. Lung squamous cell carcinoma (SCC) is
one of the predominant types of lung cancer1. Epidemio-
logical studies have shown that most patients with lung
SCC have a history of cigarette smoking2. Recently, two
spontaneous lung SCC mouse models demonstrate that a
robust chronic inﬂammatory response is associated with
lung SCC3,4. Depleting macrophages prevents lung SCC
development in L-IkkαKA/KA (KA/KA) mice3, indicating
that these macrophages act as a driving force for the
pathogenesis of lung SCC. Interestingly, these pathogenic
macrophages express marked inducible nitric oxide syn-
thase (iNOS/NOS2); however, the effect of macrophage
NOS2 on lung tumorigenesis is largely unclear.
Elevated NOS2 levels have been observed in human
lung cancer, as well as breast, brain, prostate, colorectal,
and pancreatic carcinomas5–7. Nitric oxide (NO) is one of
the major resources of oxidative stress. NOS catalyzes L-
arginine to produce NO and L-citrulline. There are three
isoforms of NOS: neuronal NOS (NOS-1), inducible NOS
(NOS2), and endothelial NOS (NOS-3). The expression of
NOS-1 and NOS-3 is constitutive and calcium/calmodu-
lin-dependent and they generate NO in the
picomolar–nanomolar range. NOS2 in macrophages is
induced by TNFα, IL-1 (interleukin-1), IFNγ, endotoxins,
or lipopolysaccharide (LPS) stimulation, and locally gen-
erates high-output quantities of NO at micromolar range
for prolonged periods of time. A NOS2 level may reﬂect
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the status of inﬂammation. The excessive oxidative stress
and inﬂammation thus form a loop, which creates a tumor
microenvironment and promotes carcinogenesis.
Cigarette smoke exposure can lead to lipid accumula-
tion in macrophages, which drives pulmonary inﬂamma-
tion8. The impaired lipid metabolism results in
cytoplasmic needle-shaped crystalline bodies and greatly
enlarged macrophage sizes (called foamy macrophages)
that express Ym-1 (or chitinase-3-protein 3, Chi3l3), a
marker for M2 macrophage9. The impaired lipid meta-
bolism has been reported in human and mouse lung
SCC10. NOS2 expression is minimal in macrophages until
these cells are stimulated11. A substrate competition for L-
arginine exits between the NOS- and arginase 1-mediated
pathways because arginase 1 converts L-arginine to L-
ornithine and urea, diminishing NO synthesis9. The bal-
ance of NOS2 and arginase 1 regulates macrophage dif-
ferentiation12. To date, the effect of NOS2 on the lipid
metabolism remains to be fully explored. Because
increased cytokines can induce NOS2 expression12, it still
needs to be examined whether the macrophage NOS2
contributes to a lung tumor microenvironment in KA/KA
mice3 or is a response to increased pulmonary inﬂam-
mation during lung carcinogenesis.
In this study, we show that NOS2 ablation inhibits
pulmonary inﬂammation, lung epithelial cell overgrowth,
and lung SCC development associated with markedly
decreased pulmonary macrophage/foamy macrophage
numbers in KA/KA mice. NOS2 null bone narrow (BM)
transplantation decreases the pulmonary macrophage
numbers and inhibits lung SCC incidence in irradiated
KA/KA chimeric mice. Also, lung epithelial cell NOS2 is
required for maintaining microenvironmental inﬂamma-
tion. Together, these results reveal a crucial role of mac-
rophage NOS2 for circulating inﬂammatory responses
and promoting lung SCC development.
Results
NOS2 ablation inhibits inﬂammatory responses and
spontaneous lung SCC in KA/KA mice
To evaluate the role of NOS2 in lung SCC development,
we crossed KA/KAmice with Nos2−/−mice for more than
ﬁve generations and generated KA/KA;Nos2−/− mice on
the FVB background. KA/KA mice at 4–10 months of age
develop spontaneous lung SCCs that express lung SCC
markers of keratin 5 (K5) and increased TRIM29 and
these mice die before 10 months due to lung SCCs or
severe systemic inﬂammation3 (Fig. 1a–c). Whereas, KA/
KA; Nos2−/−mice lived longer and developed signiﬁcantly
less lung SCCs than KA/KA mice (Fig. 1a). Two out of 12
KA/KA;Nos2−/− mice developed lung SCCs before
8 months of age and six of 12 KA/KA;Nos2−/− mice lived
to one year old (Fig. 1a). Lung SCCs derived from KA/KA
and KA/KA;Nos2−/− mice expressed K5 and TRIM29, but
NOS2 deletion reduced TRIM29 and COX2 expression in
KA/KA lungs (Fig. 1b). KA/KA;Nos2−/− lungs became soft
with normal red color compared to KA/KA lungs that
show yellow color3,13 (Fig. 1d).
Furthermore, the weights of KA/KA lungs and spleens
were signiﬁcantly increased compared to wild type (WT),
but the weights of KA/KA;Nos2−/− lungs and spleens
were slightly reduced compared to KA/KA ones (Sup-
plementary Figures S1a and b). We observed increased
inﬁltrating cells in KA/KA;Nos2−/− lungs compared to
WT lungs (Fig. 1e; Supplementary Figure S1c). Although
some KA/KA;Nos2−/− mice did not bear lung SCCs and
could survive to 12 months, they still suffered from other
phenotypes. Thus, we were not able to maintain these
mice. Together, these results suggest that NOS2 deletion
decreases lung SCC incidence.
NOS2 deletion reduces basal epithelial cell
hyperproliferation, ﬁbrosis, and inﬂammatory responses in
the lungs of KA/KA mice
Lung SCC is derived from the basal cells of lung
bronchi. Ki67-stained proliferative cells in the basal layer
of upper airway epithelium were signiﬁcantly increased in
KA/KA lungs, compared to WT lungs, and NOS2 deletion
decreased Ki67-positive basal epithelial cells in the upper
airways of KA/KA;Nos2−/− lungs compared to KA/KA
lungs (Fig. 2a and Supplementary Figure 2a). Increased
oxidative stress is associated with ﬁbrosis13. KA/KA lungs
showed yellow color and KA/KA;Nos2−/− lungs showed
red color (Fig. 1d), suggesting that induced NOS2 levels in
KA/KA lungs may contribute to ﬁbrosis development.
Masson’s trichrome staining for collagen, a ﬁbrosis mar-
ker, showed increased collagen staining in KA/KA lungs
compared to WT and that NOS2 deletion reduced col-
lagen expression (Fig. 2b), indicating that induced NOS2
contributes to the development of lung ﬁbrosis.
We further analyzed gene expression proﬁles in KA/
KA and KA/KA;Nos2−/− lungs (Fig. 2c, accession num-
ber: GSE101759). NOS2 deletion-mediated changes
include reduced expression of many chemokines (CXC
and CC), cytokines (IL), matrix metalloproteinases,
stemness cell markers, cell cycle/mitogenic activators,
and TNF and Jak inﬂammatory signaling pathways, but
increased molecules that were involved in regulating
cellular events, such as cell growth and adhesion
(Fig. 2c). These major inﬂammation-related molecular
alterations may contribute to the reduction of lung SCC
and ﬁbrosis development although KA/KA;Nos2−/− mice
still remain other phenotypes. In addition, numbers of
T cells and B cells were comparable in the lungs of KA/
KA and KA/KA;Nos2−/− mice (Supplementary Fig-
ures S2b and c). Previously, we demonstrated that
macrophage inﬁltration is required for lung SCC devel-
opment in KA/KA mice3. Thus, we focused on
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understanding the effect of macrophage NOS2 on lung
SCC development.
NOS2 deletion reduces numbers of macrophages and
foamy macrophage with impaired lipid metabolism in the
lungs
Flow cytometric analysis revealed that KA/KA lungs had
markedly increased numbers of CD45+CD11b+Gr-1−
macrophages compared to WT and that NOS2
deletion signiﬁcantly reduced macrophage numbers in
KA/KA;Nos2−/− lungs (Fig. 3a). We observed many large
foamy macrophages that are characterized by a pink
color and needle-shaped crystalline bodies in the cyto-
plasm due to lipid protein accumulation in KA/KA lungs
but not in WT lungs, as examined by hematoxylin and
eosin (H&E) histological examination (Fig. 3b). A KA/KA
Fig. 1 NOS2 deletion reduces lung SCC development. a Comparison of lung SCC incidence in KA/KA and KA/KA;Nos2−/− mice at 8 months of age
and mouse survival at 12 months of age. P-value between KA/KA and KA/KA;Nos2−/− groups is analyzed by chi-square test. b Western blotting shows
TRIM29 and COX2 levels in WT, KA/KA, and KA/KA;Nos2−/− lungs. β-actin, protein loading control. c K5 immunohistochemistry (IHC) stains lung SCCs
from KA/KA and KA/KA;Nos2−/− mice. K5 keratin 5; dark brown, positive staining. Scale bar, 50 μm. d The appearances of lungs of KA/KA and KA/KA;
Nos2−/− mice. An arrow indicates a lung SCC. e Hematoxylin and Eosin (H&E) examination of lungs of WT, KA/KA, and KA/KA;Nos2−/− mice. Scale bar,
40 μm
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foamy macrophage can be ten times bigger than a WT
macrophage and these foamy cells often form clusters,
which indeed expressed F4/80, a macrophage maker
(Fig. 3c). NOS2 deletion reduced foamy macrophage
numbers and sizes in KA/KA;Nos2−/− lungs compared to
KA/KA (Fig. 3c, d). Oil red staining further veriﬁed the
lipid accumulation in these foamy macrophages in KA/
KA lungs (Fig. 3e). NOS2 deletion attenuated the
intensity of oil red staining in the macrophages and
reduced the foamy macrophage numbers, suggesting that
NOS2-mediated changes modulate lipid metabolism in
the macrophages. Furthermore, we examined expression
Fig. 2 NOS2 deletion inhibits lung epithelial cell hyperproliferation, ﬁbrosis, and inﬂammatory responses. a Analysis of Ki67-positive
epithelial cells in basal cells of lung bronchi in WT, KA/KA, and KA/KA;Nos2−/− mice, examined by IHC staining and statistically analyzed by Student’s t-
test. Data represent mean ± SD (n= 3/group, 500 cells were counted in each group). *p < 0.05; ***p < 0.001. b Chemical Masson’s trichrome staining
in the lungs of WT, KA/KA, and KA/KA;Nos2−/− mice at 5 months of age. Blue color, positive staining. Scale bar, 50 μm. c Heat maps show gene
expression proﬁles between KA/KA and KA/KA;Nos2−/− lungs from mice at 5 months of age. All the groups between KA/KA and KA/KA;Nos2−/− lungs
were statistically analyzed by an ANOVA one-way test. Each p-value for all groups, p < 0.05
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Fig. 3 NOS2 deletion reduces inﬁltrating macrophage and foamy macrophage numbers in KA/KA lungs. a Flow cytometric analysis compares
macrophage (CD45+CD11b+Gr-1−) numbers (% or total) in lungs of WT, KA/KA, and KA/KA;Nos2−/− mice at 5 months of age. Data are statistically
analyzed by Student’s t-test. Data represent mean ± SD (n= 3/group). **p < 0.01; ***p < 0.001. b H&E staining for lungs of WT, KA/KA, and KA/KA;
Nos2−/− mice. Arrows denote foamy macrophages (Mac). A box at right bottom of WT lung shows a normal macrophage with F4/80-IHC-stained
brown color. Scale bar 40 μm. c IHC-stained F4/80 Mac (brown color) in lungs of KA/KA and KA/KA;Nos2−/− mice at 4 months of age. Scale bar, 40 μm.
d Comparison of large foamy Mac, stained by H&E, in lungs of KA/KA and KA/KA;Nos2−/− mice. Data are statistically analyzed by Student’s t-test. Data
represent mean ± SD (n= 3/group). **p < 0.01. e Oil red staining for lungs of WT, KA/KA, and KA/KA;Nos2−/−mice. Blue color, nuclear counter staining.
Scale bar, 10 μm
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of PD-L1—an antitumor blockage using a ﬂow cytometry
analysis, and found no signiﬁcant alternations in PD-L1
expression in WT, KA/KA, and KA/KA;Nos2−/− mac-
rophages (Supplementary Figure S3).
NOS2 deletion does not alter arginase 1 expression but
decreases Ym-1 expression in macrophages and NOS2
promotes macrophage migration and survival
Previously, we observed increased NOS2 expression in
KA/KA lung macrophages compared to WT3. It is still not
clear whether KA/KA macrophages expression increased
NOS2 or increased inﬂammation induces NOS2 expression.
Thus, we compared induced NOS2 levels in WT, KA/KA,
and KA/KA;Nos2−/− peritoneal macrophages following LPS
treatment. Raw macrophage cell line was used as a positive
control and KA/KA;Nos2−/− cells were used as a negative
control (Fig. 4a). Western blot analysis showed that treat-
ment with LSP induced a comparable level of NOS2 in WT
and KA/KA macrophages but did not detect NOS2
expression in untreated WT, KA/KA, and KA/KA;Nos2−/−
cells (Fig. 4a), suggesting that increased inﬂammation
induces NOS2 expression in KA/KA lungs. KA/KA mac-
rophages expressed Ym-1 (Fig. 4a), an M2 macrophage
marker9. NOS2 deletion markedly reduced Ym-1 expres-
sion in KA/KA macrophages. Treatment with LPS
decreased Ym-1 expression in KA/KA;Nos2−/− macro-
phages (Fig. 4a). Furthermore, WT lung macrophages
expressed lower levels of arginase 1 compared to KA/KA
macrophages in mice (Supplementary Figure S4). KA/KA
and KA/KA;Nos2−/− macrophages expressed comparable
levels of arginase 1, another M2 macrophage marker9, and
treatment with LPS decreased expression of arginase 1 in
KA/KA;Nos2−/− and WT macrophages (Fig. 4b, left and
right panels). Of note, the effect of LPS treatment on
reduced Ym-1 and arginase 1 expression was more in KA/
KA;Nos2−/− macrophages than in KA/KA macrophages,
suggesting that NOS2 deletion may reduce the macrophage
potential in response to inﬂammation. These results also
indicate that KA/KA macrophages were able to express
both M1 and M2 markers.
Interestingly, ﬂow cytometric analysis showed similar
peritoneal CD45+CD11b+Gr-1− macrophage numbers
in KA/KA and KA/KA;Nos2−/− mice (Fig. 5a) although
macrophage numbers were reduced in KA/KA;Nos2−/−
lungs compared to KA/KA lungs (Fig. 3a), suggesting
that NOS2 deletion may affect the migration of KA/KA
macrophages. Then, we examined cell migration and
found that KA/KA macrophages showed a stronger
potential of migration for proximal and distal movement
than KA/KA;Nos2−/− macrophages did (Fig. 5b; Sup-
plementary Figure S5a). Moreover, KA/KA macrophages
survived better than KA/KA;Nos2−/− macrophages fol-
lowing TNFα treatment (Fig. 5c; Supplementary Fig-
ure S5b). These results suggest that NOS2 induction
Fig. 4 NOS2 affects Ym-1 and arginase 1 expression in macrophages. a Western blotting shows NOS2, Ym-1, and arginase 1 levels in WT, KA/KA,
and KA/KA;Nos2−/− peritoneal macrophages treated with or without LPS (Lps, 100 ng/ml). Raw, macrophage cell line; β-actin, protein loading control.
bWestern blotting shows arginase 1 levels in WT, KA/KA, and KA/KA;Nos2−/− peritoneal macrophages treated with or without LPS (Lps, 100 ng/ml). β-
actin, protein loading control
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enhances migration and survival abilities of macrophages
in KA/KA lungs associated with a sustained chronic
inﬂammation.
NOS2 null bone marrow (BM) transplantation reduces lung
SCC incidence in irradiated KA/KA chimeric mice associated
with reduced pulmonary macrophages and foamy
macrophages
To understand the effect of NOS2 on inﬂammatory
responses in macrophages, we analyzed expression of
multiple cytokines and chemokines in KA/KA and KA/
KA;Nos2−/− macrophages (Fig. 6a). The analysis showed
increased expression of multiple cytokines in KA/KA
compared to KA/KA;Nos2−/− peritoneal macrophages
(Fig. 6a). IL-3, IL-24, and Nodal promote leukocyte pro-
liferation and differentiation14–16. IL-3 promotes the dif-
ferentiation of myeloid cells to macrophages and IL-17a
promotes NOS2 induction17. Cxcl5 has been implicated
in the limitation of inﬁltrating foamy macrophages in the
plaque area of atherosclerosis18. Of note, KA/KA;Nos2−/−
macrophages expressed a marked increase in Cxcl5
compared to KA/KA macrophages (Fig. 6a, bottom panel),
suggesting that NOS2 deletion-mediated Cxcl5 induction
may contribute to the reduction of foamy macrophage
numbers.
To determine a physiological effect of macrophage
NOS2 deletion on lung SCC development, we performed
BM transplant experiments by injecting KA/KA BM cells
into irradiated KA/KA mice or KA/KA;Nos2−/− mice, or
by injecting KA/KA;Nos2−/− BM cells into irradiated
KA/KA mice or KA/KA;Nos2−/− mice (Fig. 6b, top). KA/
KA BM-induced lung SCCs in all ﬁve irradiated KA/KA
mice, which were used as a positive control for SCC
incidence and pulmonary inﬁltrating leukocytes. KA/KA
BM-induced lung SCC in two out of ﬁve irradiated KA/
KA;Nos2−/− mice (Fig. 6b; Supplementary Figure S6),
suggesting that epithelial cell NOS2 also contributes to
lung SCC development. KA/KA;Nos2−/− BM-induced
lung SCC in one out of ﬁve irradiated KA/KA mice and
in zero out of ﬁve irradiated KA/KA;Nos2−/− mice
Fig. 5 NOS2 regulates macrophage migration and survival. a Flow cytometry compares peritoneal macrophage numbers from WT, KA/KA, and
KA/KA;Nos2−/− mice at 5 months of age. Data are statistically analyzed by Student’s t-test. Data represent mean ± SD (n= 3/group). ***p < 0.001; NS,
not signiﬁcant. b Macrophage cell migration analysis for WT, KA/KA, and KA/KA;Nos2−/− macrophages at 48 h. The distances of cell migration (see
Supplemental Fig. 4B) are statistically analyzed by Student’s t-test. Data represent mean ± SD (n= 3/group). **p < 0.01; NS, not signiﬁcant. c Flow
cytometry analyzes cell apoptosis with a TUNEL kit for KA/KA and KA/KA;Nos2−/− macrophages. Data are analyzed by Student’s t-test and represent
mean ± SD (n= 3/group). **p < 0.01
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(Fig. 6b), suggesting that macrophage NOS2 is required
for lung SCC development. WT mice receiving KA/KA
BM cells and KA/KA;Nos2−/− mice receiving KA/KA;
Nos2−/− BM cells did not develop any lung SCCs and
their lungs did not have increased pulmonary inﬁltrating
inﬂammatory cells, which were used as negative controls
Fig. 6 NOS2 regulates macrophage properties and NOS2 null bone marrow (BM) transplantation reduces lung SCC development. a
Comparison of the expression of multiple cytokines in KA/KA vs. WT macrophages or KA/KA;Nos2−/− vs. WT macrophages, as detected by RT22 Proﬁle
PCR Array. Each group contains three samples. b Top panel: a scheme for BM transplant experiment. KA/KA or KA/KA;Nos2−/− BM was injected to
irradiated KA/KA or KA/KA;Nos2−/− mice. Bottom panel: lung SCC incidence in different irradiated chimeric mice. Inﬁltrating macrophages (Mac) and
lymphocytes (LymC) in the lungs of irradiated KA/KA mice receiving KA/KA BM were used as positive controls (++++). Inﬁltrating Mac and LymC in
the lungs of irradiated WT mice receiving KA/KA BM were used as negative controls (−). Tumor incidence in irradiated KA/KA mice receiving KA/KA;
Nos2−/− BM and in irradiated KA/KA;Nos2−/− mice receiving KA/KA BM was compared with the positive control. Data are analyzed by chi-square test
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(Fig. 6b). These results conﬁrmed that NOS2 reduces
macrophage migration in vivo. In addition, NOS2 also
plays a role in the lung epithelial cells during lung SCC
development although its mechanism remains to be
determined in the future.
Discussion
In this study, we demonstrate that macrophage NOS2
promotes lung SCC development by circulating inﬂam-
matory signaling, enhancing macrophage migration and
survival, and impairing lipid metabolism. Our results
also explain that an increased inﬂammatory micro-
environment can induce NOS2 expression in KA/KA
lungs; in turn, NOS2 circulates inﬂammatory signals
between macrophages and epithelial cells, promoting
carcinogenesis.
Although we demonstrated that macrophage NOS2
promoted lung SCC development in KA/KA mice, BM
transplant experiments showed that NOS2 deletion in
the epithelial cells reduced lung tumorigenesis asso-
ciated with decreased inﬁltrating macrophage numbers
in the lungs of irradiated KA/KA;Nos2−/− mice receiving
KA/KA BM, compared to irradiated KA/KA mice
receiving KA/KA BM, suggesting that epithelial cell
NOS2 is required for circulating inﬂammation. Fur-
thermore, Ki67-stained proliferating basal cells of the
lung bronchi in KA/KA;Nos2−/− mice were signiﬁcantly
decreased compared to KA/KA lungs, suggesting that
NOS2 deletion reduces the basal cell growth in the lung
bronchi or that NOS2 promotes epithelial cell growth in
KA/KA lungs through a loop of inﬂammatory cells and
epithelial cells.
In this study and another3, we showed that lung tumor
associated macrophages (TAMs) expressed increased
NOS2, arginase 1, and Ym-1 in KA/KA mice, suggesting
that KA/KA TAMs possess both M1 and M2 features.
NOS2 deletion decreased the expression of Ym-1 in KA/
KA;Nos2−/− macrophages compared to KA/KA macro-
phages and LPS treatment in vitro further reduced Ym-1
and arginase 1 expression in KA/KA;Nos2−/− macro-
phages, indicating that NOS2 deletion attenuates the M2
potential of KA/KA macrophages, as well as reduces
responses to inﬂammatory signaling in macrophages
in vivo.
In addition to constitutively expressed NOS-1 and
NOS-3 in vivo, NOS activity has been reported in several
bacterial species (bNOS), including Staphylococcus aureus
and the notorious pathogens Bacillus anthracis19. S.
aureus is a member of the normal ﬂora of the body and is
frequently found in the nose, in the respiratory tract, and
on the skin. Thus, these NOS isoforms may provide NO
required for maintaining NO’s essential functions in the
absence of NOS2.
The BM-derived macrophages can differentiate to
foamy macrophages20 and the foamy macrophages
associated with impaired lipid metabolism can drive
inﬂammation8,21; however, the relationship between
foamy macrophages and lung tumor development has
not be investigated. In this study, we described large
foamy macrophages associated with accumulated lipid
proteins in KA/KA lungs, which was associated with
lung SCC development. NOS2 deletion reduced foamy
macrophage numbers and sizes and NOS2 null BM
transplantation reduced lung tumorigenesis with
decreased pulmonary macrophage inﬁltration, sug-
gesting that increased NOS2 may impair the lipid
metabolism in macrophages during lung carcinogen-
esis. Cxcl5 eliminates foamy macrophages18. NOS2
deletion increased Cxcl5 expression in KA/KA macro-
phages, suggesting that NOS2’s effect on the macro-
phage property may be associated with Cxcl5
regulation. The detailed mechanism underlying the
lipid metabolism in macrophages regulated by NOS2
remains to be investigated in the future. Also, we will
investigate whether lung SCC induces foamy macro-
phages in the future. The increased inﬂammasome
activity has been reported in KA/KA macrophages22,
which may contribute to the increased expression of
cytokines, chemokines, and NOS2. Overall, this ﬁnding
identiﬁes a new function of macrophage NOS2 in lung
carcinogenesis, as well as provides new insight into
therapeutic strategies for prevention and treatment of
lung SCC.
Materials and methods
Mice
The animal procedures (14-051 and 14-052) for all
animal experiments were reviewed and approved by the
Animal Care and Use Committee of the National Can-
cer Institute. L-IkkαKA/KA (KA/KA) mice express a
kinase-dead IKKα with an amino acid K44 >
A44 substitution, and also speciﬁcally express a WT
IKKα in the skin under the loricrin promoter control for
protecting the skin integrity, which was previously
described3,23. Nos2−/− mice were purchased from
Jackson laboratory (Cat# 002609). All the mice used for
this study have been crossed over nine generations to
FVB background.
Antibodies
The following antibodies were used for western blot-
ting and immunostaining, including COX2 (sc-1747-R),
NOS2 (sc-651), and arginase 1 (sc-20150, H-52) from
Santa Cruz Biotechnology, Inc., Santa Cruz, CA;
TRIM29 (ab22207); Chitinase like 3 protein 3 (Ym-1,
ab93034), and 8-OHdG (ab26842) from Abcam,
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CHEMICON International, Inc., Temecula, CA; and β-
actin (A2228) from Sigma-Aldrich.
Histopathology, western blot analysis, and
immunohistochemical (IHC) and immunoﬂuorescence
staining
The Histology and Tissue Core Facility at the Frederick
National Laboratory for Cancer Research routinely pre-
pared parafﬁn sections of mouse organs and performed
hematoxylin and eosin (H&E) staining and IHC staining
for K5, CD3, and F4/80. Eight micrometers frozen sec-
tions was immunoﬂuorescently stained overnight at 4 °C
with anti-8-OHdG antibody, and were then washed
and stained with the ﬂuorescence-conjugated secondary
antibodies for 2 h at room temperature. Finally, the sec-
tions were mounted with diamidino-2-phenylindole
(Vector Laboratories, Burlingame, CA) mounting med-
ium3. Cell lysates (15 μg) or protein extract from the tis-
sues (20 μg) were examined in acrylamide gels using
western blotting with speciﬁc antibodies and were visua-
lized by chemiluminescence, as previously described24.
Masson’s trichrome stain was performed by Histoserve,
Inc.
Array analysis for gene expression proﬁles
Total RNA was isolated from the lungs of 14-week-old
mice (WT, KA/KA, and KA/KA;Nos2−/−mice) using the kit,
according to TRIzol (Invitrogen) manufacturer instructions
and given to the Center for Cancer Research Genomics
Laboratory to perform GeneChip Mouse Genome Array 430
2.0. Raw data were then analyzed using Partek Genomics
Suite 2.0 software. The statistical signiﬁcance of expression
of interested genes was sorted or grouped. Microarray
results (accession number: GSE101759) have been deposited
at the National Center for Biotechnology Information Gene
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/).
Cell isolation and ﬂow cytometry
For pulmonary leukocyte isolation, lungs were cut into
small pieces and then digested in RPMI medium con-
taining 5% fetal calf serum, 250 U/ml of type IV col-
lagenase (Invitrogen), 100mg/ml of DNase I (Roche), and
1mmol/l of ethylenediaminetetraacetic acid (pH 8.0), at
37 °C for 30min. The homogenate was then ﬁltered with a
70-mm nylon cell strainer (BD Biosciences), washed with
HBSS medium, and resuspended in 40% Percoll (Amer-
sham Pharmacia) in Dulbecco’s modiﬁed Eagle’s medium
(BioWhittaker). The suspension was underlaid with 80%
Percoll and centrifuged for 25min at 1000×g. Leukocytes
were collected from the interphase, washed, and enum-
erated on Sysmex KX-21. Fluorescent-conjugated anti-
bodies used for analyses included CD3 (clone 500A2, 145-
2C11), CD8 (clone 53–6.7), and CD4 (clone GK1.5), which
were obtained from BD Biosciences Pharmingen; MHC II
(clone M5/114.15.2), Gr-1 (clone RB6-8C5), B220 (clone
RA3-6B2), CD11c (clone N418), F4/80 (clone BM8),
CD11b (clone M1/70), and PD-L1 (12-5983-42), which
were obtained from eBioscience; and CD45 (clone 30-F11),
which was obtained from Invitrogen. Labeled cells were
analyzed on an LSR II ﬂow cytometer (Becton Dickinson).
Data were analyzed with FCS Express software.
Isolation of mouse peritoneal macrophages
Ten-week-old female or male WT, KA/KA, and KA/KA;
Nos2−/− mice were killed and 70% ethanol was immedi-
ately used for disinfection of animal fur. Pulling the
abdominal skin with forceps, making a small incision over
the caudal half of the abdomen with scissors, and
exposing the underlying abdominal wall by retraction
were performed; care was taken pierce the abdominal wall
while incising the skin. Following lifting the abdominal
wall with forceps, 10 ml sterile PBS was injected into the
caudal half of the peritoneal cavity using a 25-gauge
needle. The entire mouse body was gently shaken for 30 s.
Then, PBS containing resident peritoneal cells was slowly
withdrawn by inserting a 25-gauge needle into the cranial
half of the peritoneal cavity. Cells were collected by cen-
trifuging at 1500×g for 8 min, and the pellet was resus-
pended with DMEM medium with 10% FBS and 1%
penicillin–streptomycin-L–glutamine for cell counting.
Cells were seeded 1 × 105/ml and replaced with fresh
RPMI medium supplemented with 10% FBS 2–3 h later.
For the experimental group, isolated macrophages were
stimulated with 100 ng/ml LPS for 18 or 12 h, and then
total RNA or protein was collected.
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was isolated from the lung tissues using the
TRI Reagent (Molecular Research Center, Inc., Cincinnati,
OH). Complementary DNA was synthesized with a
SuperScript®III First-Strand kit (Invitrogen, Cat no.
18080-051, CA). PCR conditions were used: one cycle at
95 °C for 4 min; 35 cycles at 95 °C for 30 s, 58 °C for 30 s,
and 72 °C for 50 s; and one cycle at 72 °C for 7 min.
Quantitative real-time PCR
Total RNA was isolated from lung homogenates using
TRIzol (Invitrogen) and was precipitated and reverse
transcribed (Applied Biosystems). The Mouse Inﬂam-
matory Cytokines and Receptors RT2 Proﬁler PCR
Array (PAMM-011E, SuperArray), obtained from
SABiosciences (Frederick, MD), was used to detect the
expression of murine cytokines and chemokines,
according to the manufacturer’s directions. Genes of
interest were subsequently examined using real-time
RT-PCR with the TaqMan Universal PCR Master Mix
and the ABI Prism 7300 Detection System (TaqMan;
Applied Biosystems) according to the manufacturer’s
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instructions. Gene expression was normalized to the
level of the β-actin housekeeping gene. Data were
expressed as a fold change in mRNA expression relative
to control values.
BM transfer
Recipient 4- or 5-week-old WT, KA/KA, and KA/KA;
Nos2−/−mice on an FVB background were irradiated with
950 rad using the 137Cs irradiator facility at the Frederick
National Laboratory for Cancer Research. The irradiated
mice were intravenously injected with 1 × 106 BM cells
isolated from 10-week-old KA/KA or KA/KA;Nos2−/−
mice25. Single-cell suspensions were prepared by passing
the dissociated cells from the femur and tibia through a
40-μm cell strainer and then washing with PBS.
Wound-healing assay for macrophage migration
Isolated macrophages (1.5 × 106/ml) were plated onto
coated cell culture plates with two-well inserts (Ibidi) in
DMEM with 10% FBS and 1% penicillin–streptomycin.
Cell suspension was added to the wells, allowing for
adherence and growth in designated areas only. After 24
h, the insert was removed and then the adherent mono-
layer of cells was washed with PBS, photographed in phase
contrast with a Nikon microscope (T= 0 h), and placed
back into complete growth medium with or without
treatment with LPS (200 ng/ml). The cells were photo-
graphed once following 48 h of incubation at 37 °C (T=
48 h). The distance between the two groups of cells was
measured at 0 h using Nikon imaging software and
superimposed on the image of cells at 48 h. Cells within
the boundary were then counted and sorted by distance
migrated (e.g., proximal= < 1/10th original distance, dis-
tal= > 1/10th original distance).
Apoptosis assay
Peritoneal cells collected from WT, KA/KA, and KA/KA;
Nos2−/− mice were seeded in six-well culture dishes and
washed with PBS following adherence. Remaining perito-
neal macrophages were then stimulated with TNFα (10 ng/
ml) for 72 h. Following treatment, cells were collected and
prepared, according to APO-BrdU TUNEL Assay Kit
(Invitrogen, Cat# A23210) instructions and detected using
ﬂow cytometry. The percent and mean number of apoptotic
cells were recorded as anti-BrdU positive events (per 2.5 ×
105 cells). The signiﬁcance of the data was determined by
statistical analysis and Student’s t-test.
Statistical analysis
Statistical analysis methods were indicated in the ﬁgure
legends. P-values <0.05 were considered statistically
signiﬁcant.
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